Boards, Committees and Statutory Board

Mr. Marcio Pinheiro Mendes holds a degree in Business Administration from the Goizueta Business School, at Emory University, in the United States, and an MBA from HEC Paris, in France. He worked at Accenture do Brasil, working on operational excellence projects, and later developed his career in Europe, with large technology companies, such as BEA Systems, Oracle and Adobe. He has worked in different positions in the Finance and Compliance areas, leading projects in countries such as France, Spain, Portugal, Italy, Belgium, Holland and Luxembourg. In 2011, he joined the group of founding physicians, a reference shareholder of Grupo Fleury, and from 2015 to 2020 he held the position of CEO of the holding company Integritas Participações. Appointed in 2015 to the Board of Directors of Grupo Fleury as Vice-Chairman, position he holds until the 2019 AGO, when he assumes the Presidency.

Fernando Lopes Alberto, nominated for the position of Vice-Chairman of the Board of Directors, is a doctor graduated from the Faculty of Medicine of Ribeirão Preto, USP. He held a medical residency in Hematology, Hemotherapy and Bone Marrow Transplantation at the same institution and a PhD in Internal Medicine from the Faculty of Medical Sciences at UNICAMP. From 1998 to 2000, he worked as a doctor and collaborating researcher at the Blood Center at UNICAMP, performing assistance and academic activities, with 25 works published in indexed international journals and elected for three years as an honored professor of the class of medical graduates. He worked at Fleury as a medical advisor (Molecular Biology and Hematology) until 2008, when he transferred to Fleury’s Information Technology area, serving for two years as project manager. In 2010, he took over management of the Hospitals business area. In 2011 he completed an International Executive MBA offered by a consortium of five business schools (FGV / Brazil; EGADE / Mexico; UNC / USA; RSM / Netherlands; CUHK / Hong Kong: OneMBA). In 2015, he took the course for training IBGC Board Members.

Rui Monteiro de Barros Maciel, physician, scientist and university professor, appointed to the position of effective member of the Board of Directors, has been a partner of the Fleury Group since 1983 and Full Member of the National Academy of Medicine since 2017. He was Full Professor of Endocrinology at Escola Paulista of Medicine, Federal University of São Paulo (EPM/UNIFESP) from 1992 to 2015, where he is currently Professor Emeritus. He graduated in Medicine in 1970 from EPM/UNIFESP, where he was a Resident Physician in Internal Medicine and Endocrinology, obtained a Master’s and Doctorate and spent his entire teaching and research career, becoming a Full Professor in 1992. at the University of California Los Angeles (1976-78) and was Visiting Professor at Harvard Medical School (1986-87). He has guided around 50 graduate students, who are now medical leaders in Brazil and abroad, in Master’s and Doctorate programs. He has published over 250 research papers, written nearly 120 chapters in medical textbooks, and edited 6 books. He has presented over 600 conferences in Brazil and abroad. He has been at Fleury since 1979, where he was recruited as a consulting physician in Endocrinology, a position he still holds today; he was Director of Services (1983-86 and 1988-95), Medical Director (1995-2010), Director of Organizational Culture (2011-19) and has been a Member of the Board of Directors since 2019. It continues to play a role in the Company’s Organizational Culture, where it contributes to defining and cultivating the values, traits and essence of Grupo Fleury for the diverse group of collaborators nationwide, with the purpose of disseminating a vigorous culture, oriented to the patient and provider of best solution in medicine.

Luiz Carlos Trabuco Cappi, nominated for re-election as an effective member of the Board of Directors, is an external member with a degree in Philosophy and a postgraduate degree in Socio-Psychology from Fundação Escola de Sociologia e Política de São Paulo. He began his career 48 years ago, dedicating his entire professional life to the Bradesco Organization. He was Investor Relations Officer and, as Executive Vice-President of Banco Bradesco, from 1999 to 2009, accumulated, for 6 (six) years, the Presidency of Grupo Bradesco Seguros. He chaired the Board of Directors of Banco Bradesco from March 2009 to March 2018, accumulating the position of Vice-Chairman of the Board of Directors until October 2017, when he was elevated to Chairman of the Board of Directors. He was Chairman of the Board of Directors of Odontoprev S.A., Member of the Board of Directors of ArcelorMittal Brasil, Member of the Strategic Committee of Vale S.A., Chairman of the Marketing and Funding Commission of the Brazilian Association of Real Estate Credit and Savings Entities – ABECIP, President of the Association National Private Pension Plan – ANAPP, President of the National Supplementary Health Federation – FENASAÚDE, President of the Council of Representatives and Executive Board of the National Confederation of Financial Institutions – CNF, Member of the Superior Council and Vice-President of the National Confederation of General Insurance, Private Pension and Life, Supplementary Health and Capitalization – CNSeg, Member of the Board of Directors and Advisory Board of FEBRABAN – Brazilian Federation of Banks and Full Member of the Association Internationale pour I’Etude de I’Economie de I’Assurance – Association of Genève , Geneva, Switzerland.

Mr. Samuel Monteiro dos Santos Júnior, nominated for re-election as a member of the Board of Directors, has a degree in Law from the Cândido Mendes Law School, in Business Administration and Accounting from the Federal University of Rio de Janeiro. Mr. Samuel is a member of the Company’s board of directors. He is also a member of the Board of Directors and Coordinator of the Audit Committee of Bradesco Saúde S.A., Odontoprev S.A., a publicly traded company and Brasildental Operadora de Planos Odontologicos and Swiss RE. Currently, he is also a member of the Board of Directors and held the position of Chief Executive Officer of BSP Empreendimentos Imobiliários S.A. and its subsidiaries. Until 03/31/2011, he held the position of Executive Vice-President of the companies that make up the Bradesco Group. Mr. Samuel held positions in the management of companies belonging to the Grupo Bradesco de Seguros e Previdência, whose commanding company is Bradesco Seguros S.A., which has Bradseg Participações S.A. as its parent company. Mr. Samuel Monteiro is part of the Management of companies linked to the shareholder company of Fleury S.A., namely, Bradesco Saúde S.A. These companies belong to the Bradesco Seguros Group, whose commanding company is Bradesco Seguros S.A., whose parent company is Bradseg Participações S.A., one of the Company’s shareholders.

Mr. Ivan Luiz Gontijo Junior, nominated for re-election as a member of the Board of Directors, holds a law degree from the Catholic University of Petrópolis. Legal Director of Grupo Bradesco Seguros. Former professor of Commercial Law at the Catholic University of Petrópolis and Professor of Insurance Law at the Cândido Mendes Law School. General Director of Bradesco Seguros, Bradesco Capitalização S.A., Bradseg Participações S.A., Mediservice Operadora de Planos de Saúde S.A. Bradesco Saúde S.A., Bradesco Vida e Previdência S.A., Bradesco Auto/RE Companhia de Seguros, Atlântica Companhia de Seguros, BSP Affinity Ltda. Member of the Legal Committee of IESS – Institute of Supplementary Health Studies. He sits on the Board of Directors, as an Alternate Member, of Companhia Brasileira de Gestão de Serviços and Brasildental Operadora de Planos Odontologicos and a full member of Odontoprev S.A.

Roberto holds a degree in Business Administration from EAESP/FGV and completed the Owner/President Management Program at Harvard Business School. He has been a controlling partner of Odontoclinic S/A for 14 years. He also works as an angel investor through HBS Alumni Angels of Brazil and is a member of the board of directors of Klabin. Previously, he worked at Votorantim Novos Negócios and Tarpon Investimentos and was Chief Financial Officer of Direcional Engenharia S/A. He also served as a member of the board of directors of Companhia de Saneamento de Minas Gerais – COPASA and Tarpon Investment Group.

Graduated in Medicine from the Federal University of Minas Gerais/UFMG. In São Paulo, he obtained a specialization degree in General Practice, a Master’s Degree in Clinical Endocrinology from the Escola Paulista de Medicina and a Doctorate in Clinical Endocrinology from UNIFESP/Escola Paulista de Medicina, working with Immunology and Genetics of Diabetes. Victor served as Assistant Professor at the Medical Residency in Endocrinology at Santa Casa, where he implemented the Endocrinology Research Center (Cepen). At Cepen, he presented more than 150 scientific papers at congresses and published more than 30 papers in highly prestigious scientific journals. At Hermes Pardini, he was responsible for the Endocrinology and Functional Tests sector, implemented the Human Genetics, Criovida (Umbilical Cord Bank, Semen Bank and Cellular Technology Center) and Cytogenetics departments. During the COVID-19 pandemic, he played an important role in the identification and sequencing of Sars-Cov-2, and in studies of the distribution of the different strains of Covid-19 across Brazil. He has been with Hermes Pardini since 1984.

Graduated in Medicine from the Federal University of Minas Gerais/UFMG with a specialization in Clinical Pathology at the Hospital das Clínicas of the aforementioned institution. She holds a Master’s degree in Microbiology from UFMG and a PhD in Molecular Diagnosis from Unifesp-Escola Paulista de Medicina. She served as a Fellow in the Department of Molecular Biology at the Johns Hopkins University School of Medicine (JHUSOM), located in Baltimore / USA, and Fellow at the Karolinska Institute, at the University of Solsna, Sweden. At Hermes Pardini, she set up the Department of Molecular Biology and was responsible for the Departments of Immunology and Serology. She has been working at Hermes Pardini since 1984.

Mr. Márcio Moura, an independent member of the Board of Directors, holds a degree in Law from Universidade Federal de Minas Gerais/UFMG (2009) and a Master’s degree in Business Law from the Faculty of Law at Largo de São Francisco, Universidade de São Paulo – USP (2018). Currently, he also serves as the CEO of Futuro Capital and Arpium, companies dedicated to implementing best practices in financial planning for their clients in the Brazilian market. Mr. Márcio Moura has worked in the legal departments of numerous financial institutions, having served as Legal Director at Banco Modal S.A. (2022/2023), Legal Manager at Banco Inter (2020/2022), Head of Legal South America at Banco ABN AMRO S.A. (2016/2020), and a member of the legal team at Banco ABC Brasil S.A. (2010/2012). Additionally, Mr. Márcio Moura worked in the Capital Markets department at the law firm Demarest Advogados (2012/2014) and at Santos Neto Advogados (2014/2016). He was also a member of the Legal Committee of ABBI – Brazilian Association of International Banks (2016/2020) and the Legal Committee of Febraban (2020/2022).

Graduated in Medicine from UNIFESP, with a residency in Clinical Medicine and Endocrinology from UNIFESP. PhD in Endocrinology from the Department of Clinical Medicine at UNIFESP. Adjunct Professor of Endocrinology at UNIFESP from 1983 to 1997; Post-Doctorate in Molecular Biology from Harvard Medical School (Joslin Diabetes Center) in 1988-1989 with a scholarship from the Fogarty International Center; Former Board Member of the Fleury Group, where he held the position of President from 1998 to 2005; Executive MBA in 1993 from FIA linked to FEA/USP – Advanced Management Program in 1997 from Fundação Dom Cabral in partnership with INSEAD in France. He is currently a member of the Doctor-Partners group, a reference shareholder of the Fleury Group and invests together with his Family in Impact and Philanthropic Projects (Meraki Fund).

Mr. Manoel, nominated for re-election as an alternate to Mr. Ivan Luiz Gontijo Junior on the Board of Directors, he is Chief Executive Officer of Bradesco Saúde S.A. and Mediservice Operadora de Planos de Saúde S.A. and CEO of Bradesco Saúde S.A. He was Director of Bradesco Dental S.A. (merged by Odontoprev S.A.). He is Vice-Chairman of the Board of Directors of Odontoprev and Member of the Board of Directors of Companhia Brasileira de Gestão de Serviços. Technical Director of Hospital Sírio Libanês in São Paulo, in 2006; Officer at Sul América Seguros, from August 2001 to August 2005 and Technical Operations Officer at Medial Saúde S.A., from January 1998 to August 2001. Mr. Manoel Peres is part of the Management of Bradesco Saúde S.A and Mediservice Operadora de Planos de Saúde S.A. companies linked to companies that belong to the Bradesco Seguros Group, whose commanding company is Bradesco Seguros S.A., whose parent company is Bradseg Participações S.A., a shareholder of the Company. Additionally, Bradesco Saúde S.A also holds a stake in Odontoprev S.A.

Mauricio Minas Joined Banco Bradesco S.A. in July 2009, as Executive Managing Director. In January 2014 he was elected Executive Vice President. From March 2018 to January 2019, he accumulated the position of Member of the Board of Directors and Executive Vice President. As of January 2019, he has only held the position of Board Member. Graduated in Electrical Engineering from the Polytechnic School of the University of São Paulo – Poli/USP. And with Specialization in Data Communication and Software Development by NCR USA, in addition to the University Extension Course in Finance by Wharton Business School, in the USA and the Executive Development Programs by Columbia University – New York, USA and for Corporate Directors of Boards in Business Administration from Harvard Business School, Boston, USA. He is currently a member of the Managing Board and Managing Director of Fundação Bradesco, of the Advisory Board of IBM Corporation, of the Board of Directors of B3 S.A. – BRASIL, BOLSA, BALCÃO, the Board of Directors of Bradespar S.A., the Board of Directors of Bradseg Participações S.A., the Board of Directors of Bradesco Saúde S.A., the Board of Directors of Next Tecnologia e Serviços Digitais S.A., the Board of Directors of EFMA and the Strategic Partner of the WEF (World Economic Forum).
He was CEO of Scopus Tecnologia Ltda., Chairman of the Board of Directors of BBC Processodora S.A., Member of the Board of Directors of NCR Brasil – Indústria de Equipamentos para Automação S.A., Member of the Board of Directors of Fidelity Processamento e Serviços S.A. Member of the Board of Directors of Aquarius Participações S.A., Member of the Board of Directors of Chain Serviços e Contact Center S.A., Member of the Board of Directors of MPO – Processodora de Pagamentos Móveis S.A., Executive Vice-President of CPM Braxis S.A., Director of Support Services at group of Brazilian IT companies Eletrodigi, Flexidisk and Polymax and Senior Analyst at Banco Itaú S.A.

Rogério Rabelo is a physician graduated from the Faculty of Medicine of the Federal University of Goiás, with a PhD from the University of São Paulo, a post-doctorate from McGill University/Canada and an MBA from FIA/University of São Paulo. At Grupo Fleury, he is part of the reference shareholder group, was a member of the board of directors (2013-2014) and, before that, executive director of operations, director of health management, director of new business, product manager and medical advisor (1999-2012). He was also a partner, member of the board of directors and director of the holding company of Grupo Dalben (2014-2023), a home care and transition hospital company in São Paulo. In Brazil, he is currently a member of the board of directors and the philanthropy committee of Associação Umane, an independent, exempt and non-profit civil association that supports initiatives in the public health area that impact the Unified Health System (SUS). He is also a board member and volunteer director of Health at the philanthropic ILPI Casa Ondina Lobo, and a member of the Executive Board of the Brazil-Canada Chamber of Commerce. Abroad, he is currently a board member and coordinator of the governance committee of The ImPact, a non-profit association based in the USA, whose purpose is to systematically improve the resolution of social and environmental problems, by increasing the flow of capital for investments that generate measurable impact.

Graduated in Medicine from the Faculdade Ciências Médicas de Santos, Fundação Lusíada, in 1982. She completed her residency in Clinical Medicine, Hematology and Hemotherapy at the Universidade Estadual de Campinas, UNICAMP, from 1983 to 1986. She defended her Master’s degree (1989), Doctorate (1993) and Habilitation (2003) at the Escola Paulista de Medicina-UNIFESP. She completed an internship at The Southwest Biomedical Research Institute, Scottsdale, AZ, USA, in 1990, with a CAPES scholarship, and at St. Jude Children’s Hospital, Memphis, TN, USA, in November 1995, with a CNPq scholarship. In 2003, she became a partner at Fleury. To expand her knowledge in administration and management, in 2010, she took the course “Finance for Executives” at Insper; in 2011, “The Soul of Leadership” at the Kellog School of Management and “Best Practices in Corporate Governance” at the Brazilian Institute of Corporate Governance; and an International MBA at FGV-SP from August 2013 to June 2015. From 2009 to 2012, she was president of the Fleury Institute, a non-profit organization and a center for debates, generators and disseminators of knowledge on Human Sciences subjects related to Medicine. In 2012, she was the coordinator of physicians in 10 hospitals where Fleury operated. From 2012 to 2013, she was president of the holding company Core, owned by Fleury partners.

Born in Araçatuba – São Paulo, on February 25, 1977, he has a degree in Marketing and Supply Chain, as well as a master’s degree in Business Administration from Fundação Getúlio Vargas (EAESP) and a course in Executive Education, Marketing, Strategy and Leadership at Harvard Business School. He served as CEO of Grupo Fleury S.A. for 6 years, in 2021 he joined Grupo Bradesco Seguros, where he is currently CEO of Bradesco Saúde S.A., Mediservice Health Insurance Operator S.A., Bradesco Saúde – Health Insurance Operator S.A., Bradesco Diagnostics in Health S.A. and Novamed Gestão de Clínicas Ltda., General Director of Bradesco Gestão de Saúde S.A., Managing Director of BSP Affinity Ltda. and Director of Bradseg Promotora de Vendas S.A., he is also a full member of the Board of Directors of Brasil dental Operadora de Planos Odontológicos S.A. and of the Brazilian Service Management Company (Orizon).

Bachelor of Laws from the Faculty of Law of Faculdades Metropolitanas Unidas, class of 1998. Specialist in Civil Procedural Law from the Pontifical Catholic University of São Paulo. He worked at the law firm “Jeremias Alves Pereira Filho S/C.” from 1993 to 1998. He is a partner at MELO ALMADA ADVOGADOS ASSOCIADOS, and currently holds a seat as a member of the Board of Directors of Bombril S.A. – in Judicial Recovery and Chairman of the Board of Directors of Siderúrgica J.L. Aliperti S.A., member of the Fiscal Council of Klabin S.A., having been a member of the Board of Directors of Americanas S.A. – in Judicial Recovery, member of the Fiscal Council of Construtora Beter S.A., member of the Fiscal Council of Brasil Ecodiesel (currently Terra Santa Agro), member of the Fiscal Council of Gerdau S.A., member of the Fiscal Council of Metalúrgica Gerdau S.A., member of the Fiscal Council of JSL Logística S.A., member of the Fiscal Council of Azevedo & Travassos S.A. and member of the Fiscal Council of of the Fiscal Council of Vulcabrás S.A..

Mr. Jeane Tsutsui is currently CEO of Grupo Fleury. She started her career at Fleury in 2001 as a cardiologist, and migrated from a medical career to an executive 14 years ago. Held the roles of Manager and Director in the areas of R&D and Knowledge Management, Executive Medical Director (2012 to 2018) and Executive Business Director (2018-2021). Graduated in Medicine at the Ribeirão Preto Medical School – USP, resided in Clinical Medicine at Hospital das Clínicas at USP and in Cardiology at Instituto do Coração (InCor) -USP. She has a doctorate in Cardiology from Faculdade de Medicina da USP, Post-doctorate from the University of Nebraska Medical Center and is a Free-Professor of Cardiology at the Faculdade de Medicina da USP. Her management background includes an MBA in Knowledge, Innovation and Technology from FIA, and executive programs at Harvard Business School, Wharton and Sloan School of Management at MIT.

Mr. Rizzatti has an MD from Medical School of Ribeirão Preto at the University of São Paulo, residency in Internal Medicine and fellowship in Hematology and Blood Banking from the Clinics Hospital of Ribeirão Preto of the University of São Paulo. He has a PhD in Medical Sciences from the University of São Paulo, a visiting fellowship from the National Institutes of Health, in Bethesda, MD, and an Executive MBA from Fundação Dom Cabral. Mr. Rizzatti first started at Fleury in 2007 as a consultant physician in Hematology. Since then, he has hold administrative positions in R&D, knowledge management and Laboratory Medicine.

Mr. José Antonio Filippo holds a degree in civil engineering from the Federal University of Rio de Janeiro and is an alumni of the Leader Development Program at Harvard Business School. José Antonio Filippo had been CFO at Natura & Co since 2018, having previously held positions as Chief Financial Officer at Embraer (2012-2018), GPA (2010-2012), CPFL (2004-2010), among other prominent companies in its segments.

Has a degree in medicine with specialization in Gastroenterology from the Federal University of Minas Gerais/UFMG. Has an Executive MBA from the Dom Cabral Foundation (FDC), with an international program at the Kellogg School of Management (Chicago-USA). Has a post-graduate qualification in Strategic Business Management from CEPEAD/UFMG. Before becoming Chief Executive Officer Roberto was the company’s Director of Diagnostic Medicine. He has been with the company since 2003.

Ms. Patricia Maeda holds a degree in Mechanical Engineering from the Polytechnic School – USP and has a postgraduate degree in Business Administration from CEAG – FGV, as well as an Executive MBA in Business Administration from OneMBA – FGV. She began her career at Grupo Fleury in 2008 as a Senior Analyst of Strategy and Innovation and later took on managerial roles in the areas of Strategy, Innovation and R&D, Market, Products and Commercial Planning and Marketing. Additionally, she has worked in Business and Commercial Management. Currently, Ms. Patricia Maeda is the President of the B2C Business Unit.